Faeth Therapeutics, Inc.
NASDAQFaeth Therapeutics is at the centre of a striking divergence this week: short sellers are rapidly covering a historically extreme position while the company's own CFO is stepping in to buy shares on the open market. The insider angle is the clearest signal of the week. CFO Brian Stephenson bought shares across multiple transactions on both June 22 and June 23, accumulating roughly…
SNSE short borrow utilization hits 100%, pinned at maximum for 10 consecutive days as short interest remains elevated at 69.7% of free float.
Snapshot as of 28 Jun 2026
Faeth Therapeutics is at the centre of a striking divergence this week: short sellers are rapidly covering a historically extreme position while the company's own CFO is stepping in to buy shares on the open…
Sensei Biotherapeutics heads into its May 22 earnings call in one of the most extreme short-side configurations available in the market today. The borrow market is comprehensively seized up. Short interest has reached…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for FTH — free to start on ORTEX.
Sign up for free →Open FTH on ORTEX